NOVARTIS FDA Approval NDA 050625

NDA 050625

NOVARTIS

FDA Drug Application

Application #050625

Documents

Letter2004-06-17
Letter2004-06-17
Letter2005-07-26
Letter2012-09-05
Label2003-03-05
Label2004-03-03
Label2005-07-26
Label2006-03-10
Label2009-10-14
Label2010-05-07
Label2012-08-31
Label2015-04-01
Letter2004-02-27
Letter2004-06-17
Letter2006-03-23
Letter2009-11-10
Letter2010-05-06
Letter2013-05-07
Letter2015-04-02
Label2003-03-05
Label2004-03-03
Label2013-05-09
Letter2022-04-14
Label2022-04-20

Application Sponsors

NDA 050625NOVARTIS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE;ORAL25MG1SANDIMMUNECYCLOSPORINE
002CAPSULE;ORAL100MG1SANDIMMUNECYCLOSPORINE
003CAPSULE;ORAL50MG1SANDIMMUNECYCLOSPORINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1990-03-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1991-11-21PRIORITY
LABELING; LabelingSUPPL3AP1990-08-24
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1992-12-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1992-12-30PRIORITY
LABELING; LabelingSUPPL9AP1991-06-10
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1992-02-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1992-11-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1993-03-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1992-11-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1993-05-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1994-05-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1994-05-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1995-03-07PRIORITY
LABELING; LabelingSUPPL19AP1994-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1995-01-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1995-11-21PRIORITY
LABELING; LabelingSUPPL22AP1995-11-21STANDARD
LABELING; LabelingSUPPL23AP1996-08-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1996-04-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1998-03-30PRIORITY
LABELING; LabelingSUPPL27AP2000-10-04STANDARD
LABELING; LabelingSUPPL28AP1999-12-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2000-06-30PRIORITY
LABELING; LabelingSUPPL30AP2003-02-14STANDARD
LABELING; LabelingSUPPL32AP2003-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2002-01-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2002-04-12PRIORITY
LABELING; LabelingSUPPL39AP2004-02-06STANDARD
LABELING; LabelingSUPPL40AP2004-02-06STANDARD
LABELING; LabelingSUPPL43AP2005-07-19STANDARD
LABELING; LabelingSUPPL44AP2006-03-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL45AP2007-07-20N/A
LABELING; LabelingSUPPL47AP2009-10-08UNKNOWN
LABELING; LabelingSUPPL48AP2010-04-30UNKNOWN
LABELING; LabelingSUPPL49AP2012-08-30STANDARD
LABELING; LabelingSUPPL53AP2013-05-03STANDARD
LABELING; LabelingSUPPL55AP2015-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL57AP2016-01-06PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL60AP2022-03-16N/A

Submissions Property Types

SUPPL2Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL20Null0
SUPPL21Null0
SUPPL24Null0
SUPPL25Null0
SUPPL29Null0
SUPPL33Null0
SUPPL34Null0
SUPPL47Null7
SUPPL48Null7
SUPPL49Null15
SUPPL53Null6
SUPPL55Null31
SUPPL57Null0

TE Codes

001PrescriptionAB2
002PrescriptionAB2
003PrescriptionBX

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50625
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.